Abstract
Nearly 97% of the human genome is non-coding DNA. The intron occupies most of it around the gene-coding regions. Numerous intronic sequences have been recently found to encode microRNAs (miRNAs), responsible for RNA-mediated gene silencing through RNA interference (RNAi)-like pathways. miRNAs, small single-stranded regulatory RNAs capable of interfering with intracellular messenger RNAs (mRNAs) that contain either complete or partial complementarity, are useful for the design of new therapies against cancer polymorphism and viral mutation. This flexible characteristic differs from double-stranded siRNAs (small interfering RNAs) because more rigid complementarity is required for siRNA-induced RNAi gene silencing. miRNAs were firstly discovered in Caenorhabditis elegans as native RNA fragments that modulate a wide range of genetic regulatory pathways during embryonic development. Currently, varieties of miRNAs are widely reported in plants, animals, and even microorganisms. Intronic miRNA is a new class of miRNAs derived from the processing of gene introns. The intronic miRNAs differ from previously described intergenic miRNAs due to the requirement of type II RNA polymerases (Pol-II) and spliceosomal components for their biogenesis. Several kinds of intronic miRNAs have been identified in C. elegans, mouse, and human cells. However, neither function nor application has been reported. Here, we show that, for the first time, intron-derived miRNAs are able to induce RNA interference not only in human and mouse cell lines but also in zebrafish, chicken, and mouse, which demonstrates the evolutionary preservation of the intron-mediated gene silencing through miRNA functionality in cell and in vivo. Based on this novel mechanism, numerous biomedical applications have been developed, including cosmetic skin whitening, transgenic animal generation, anti-viral vaccination and therapy, and somatic cell reprogramming into induced pluripotent stem (iPS) cells. These findings suggest an important miRNA-mediated gene regulatory system, which fine-tunes a variety of cellular and developmental events through the mechanism of RNAi-like gene silencing.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ambros, V., Lee, R.C., Lavanway, A., Williams, P.T., and Jewell, D. (2003) MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol, 13, 807–818.
Lin, S.L., Chang, D., Wu, D.Y., and Ying, S.Y. (2003) A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. Biochem Biophys Res Commun, 310, 754–760.
Rodriguez, A., Griffiths-Jones, S., Ashurst, J.L., and Bradley, A. (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res, 14, 1902–1910.
Lin, S.L., Chuong, C.M., and Ying, S.Y. (2001) A novel mRNA-cDNA interference phenomenon for silencing bcl-2 expression in human LNCaP cells. Biochem Biophys Res Commun, 281, 639–644.
Ying, S.Y. and Lin, S.L. (2004) Intron-derived microRNAs – fine tuning of gene functions. Gene, 342, 25–28.
Clement, J.Q., Qian, L., Kaplinsky, N., and Wilkinson, M.F. (1999) The stability and fate of a spliced intron from vertebrate cells. RNA, 5, 206–220.
Parrish, S., Fleenor, J., Xu, S., Mello, C., and Fire, A. (2000) Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol Cell, 6, 1077–1087.
Holen, T., Amarzguioui, M., Wiiger, M.T., Babaie, E., and Prydz, H. (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res, 30, 1757–1766.
Hutvagner, G. and Zamore, P.D. (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297, 2056–2060.
Zeng, Y., Yi, R., and Cullen, B.R. (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A, 100, 9779–9784.
Hall, I.M., Shankaranarayana, G.D., Noma, K., Ayoub, N., Cohen, A., and Grewal, S.I. (2002) Establishment and maintenance of a heterochromatin domain. Science, 297, 2232–2237.
Llave, C., Xie, Z., Kasschau, K.D., and Carrington, J.C. (2002) Cleavage of scarecrow-like mRNA targets directed by a class of arabidopsis miRNA. Science, 297, 2053–2056.
Rhoades, M.W., Reinhart, B.J., Lim, L.P., Burge, C.B., Bartel, B., and Bartel, D.P. (2002) Prediction of plant microRNA targets. Cell, 110, 513–520.
Lee, R.C., Feibaum, R.L., and Ambros, V. (1993) The C. elegans heterochromic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843–854.
Reinhart, B.J., Slack, F.J., Basson, M., Pasquinelli, A.E., Bettinger, J.C., Rougvie, A.E., Horvitz, H.R., and Ruvkun, G. (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 403, 901–906.
Lau, N.C., Lim, L.P., Weinstein, E.G., and Bartel, D.P. (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science, 294, 858–862.
Brennecke, J., Hipfner, D.R., Stark, A., Russell, R.B., and Cohen, S.M. (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25–36.
Xu, P., Vernooy, S.Y., Guo, M., and Hay, B.A. (2003) The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol, 13, 790–795.
Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A., and Tuschl, T. (2003) New microRNAs from mouse and human. RNA, 9, 175–179.
Mourelatos, Z., Dostie, J., Paushkin, S., Sharma, A., Charroux, B., Abel, L., Rappsilber, J., Mann, M., and Dreyfuss, G. (2002) miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev, 16, 720–728.
Zeng, Y., Wagner, E.J., and Cullen, B.R. (2002) Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell, 9, 1327–1333.
Lin, S.L., Chuong, C.M., and Ying, S.Y. (2001) D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections. Curr Cancer Drug Targets, 1, 241–247.
Lin, S.L. and Ying, S.Y. (2005) D-RNAi-based therapeutics. In: Los, M. and Gibson, S. (Eds.) Apoptotic Pathways as Targets for Novel Therapies in Cancer & Other Diseases. Kluwer Press, New York, pp. 275–296.
O’Donnell, K.A. and Boeke, J.D. (2007) Mighty Piwis defend the germline against genome intruders. Cell, 129, 37–44.
Handa, V., Saha, T., and Usdin, K. (2003) The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer. Nucleic Acids Res, 31, 6243–6248.
Krol, J., Fiszer, A., Mykowska, A., Sobczak, K., de Mezer, M., and Krzyzosiak, W.J. (2007) Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell, 25, 575–586.
Lin, S.L., Chang, D.C., and Ying, S.Y. (2005) Asymmetry of intronic pre-microRNA structures in functional RISC assembly. Gene, 356, 32–38.
Danin-Kreiselman, M., Lee, C.Y., and Chanfreau, G. (2003) RNAse III-mediated degradation of unspliced pre-mRNA and lariat introns. Mol Cell, 11, 1279–1289.
Yi, R., Qin, Y., Macara, I.G., and Cullen, B.R. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev, 17, 3011–3016.
Lin, S.L., Chang, S.J.E., and Ying, S.Y. (2006) First in vivo evidence of microRNA-induced fragile X mental retardation syndrome. Mol Psychiatry, 11, 616–617.
Lee, Y.S., Nakahara, K., Pham, J.W., Kim, K., He, Z., Sontheimer, E.J., and Carthew, R.W. (2004) Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell, 117, 69–81.
Tang, G. (2005) siRNA and miRNA: an insight into RISCs. Trends Biochem Sci, 30, 106–114.
Liquori, C.L., Ricker, K., Moseley, M.L., Jacobsen, J.F., Kress, W., Naylor, S.L., Day, J.W., and Ranum, L.P.W. (2001) Myotinic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science, 293, 864–867.
Fu, Y.H., Kuhl, D.P.A., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S. et al. (1991) Variation of the CGG repeat X site results in genetic instability. Resolution of Sherman paradox. Cell, 67, 1047–1058.
Hagerman, R.J., Staley, L.W., O’Conner, R., Lugenbeel, K., Nelson, D., McLean, S.D., and Taylor, A. (1996) Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics, 97, 122–126.
Jin, P., Zarnescu, D.C., Zhang, F., Pearson, C.E., Lucchesi, J.C., Moses, K., and Warren, S.T. (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron, 39, 739–747.
Genc, B., Muller-Hartmann, H., Zeschnigk, M., Deissler, H., Schmitz, B., Majewski, F., von Gontard, A., and Doerfler, W. (2000) Methylation mosaicism of 5ʹ-(CGG)(n)-3ʹ repeats in fragile X, premutation and normal individuals. Nucleic Acids Res, 28, 2141–2152.
Jin, P., Alisch, R.S., and Warren, S.T. (2004) RNA and microRNAs in fragile X mental retardation. Nat Cell Biol, 6, 1048–1053.
Miyagishi, M. and Taira, K. (2002) U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol, 20, 497–500.
Lee, N.S., Dohjima, T., Bauer, G., Li, H., Li, M.J., Ehsani, A., Salvaterra, P., and Rossi, J. (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol, 20, 500–505.
Paul, C.P., Good, P.D., Winer, I., and Engelke, D.R. (2002) Effective expression of small interfering RNA in human cells. Nat Biotechnol, 20, 505–508.
Xia, H., Mao, Q., Paulson, H.L., and Davidson, B.L. (2002) siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol, 20, 1006–1010.
McCaffrey, A.P., Meuse, L., Pham, T.T., Conklin, D.S., Hannon, G.J., and Kay, M.A. (2002) RNA interference in adult mice. Nature, 418, 38–39.
Gunnery, S., Ma, Y., and Mathews, M.B. (1999) Termination sequence requirements vary among genes transcribed by RNA polymerase III. J Mol Biol, 286, 745–757.
Schramm, L. and Hernandez, N. (2002) Recruitment of RNA polymerase III to its target promoters. Genes Dev, 16, 2593–2620.
Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H., and Williams, B.R. (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol, 5, 834–839.
Lin, S.L. and Ying, S.Y. (2004) Combinational therapy for HIV-1 eradication and vaccination. Int J Oncol, 24, 81–88.
Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H., and Schreiber, R.D. (1998) How cells respond to interferons. Annu Rev Biochem, 67, 227–264.
Grimm, D., Streetz, K.L., Jopling, C.L., Storm, T.A., Pandey, K., Davis, C.R., Marion, P., Salazar, F., and Kay, M.A. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441, 537–541.
Lin, S.L. and Ying, S.Y. (2004) New drug design for gene therapy – taking advantage of introns. Lett Drug Des Discov, 1, 256–262.
Lin, S.L. and Ying, S.Y. (2004) Novel RNAi therapy – intron-derived microRNA drugs. Drug Des Rev, 1, 247–255.
Zhou, H.S.L., Xia, X.G., and Xu, Z. (2005) An RNA polymerase II construct synthesizes short hairpin RNA with a quantitative indicator and mediates high efficient RNAi. Nucleic Acid Res, 33, e62.
Chung, K.H., Hart, C.C., Al-Bassam, S., Avery, A., Taylor, J., Patel, P.D., Vojtek, A.B., and Turner, D.L. (2006) Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acid Res, 34, e53.
Xia, X.G., Zhou, H., Samper, E., Melov, S., and Xu, Z. (2006) Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet, 2, e10.
Nott, A., Meislin, S.H., and Moore, M.J. (2003) A quantitative analysis of intron effects on mammalian gene expression. RNA, 9, 607–617.
Zhang, G., Taneja, K.L., Singer, R.H., and Green, M.R. (1994) Localization of pre-mRNA splicing in mammalian nuclei. Nature, 372, 809–812.
Ghosh, S. and Garcia-Blanco, M.A. (2000) Coupled in vitro synthesis and splicing of RNA polymerase II transcripts. RNA, 6, 1325–1334.
Bateman, J.R. and Wu, C.T. (2007) DNA replication and models for the origin of piRNAs. Bioessays, 29, 382–385.
Lin, S.L., Chang, D.C., and Ying, S.Y. (2007) Hyaluronan stimulates transformation of androgen-independent prostate cancer. Carcinogenesis, 28, 310–320.
Lin, S.L. and Ying, S.Y. (2006) Gene silencing in vitro and in vivo using intronic microRNAs. Methods Mol Biol, 342, 295–312.
Lin, S.L., Chang, S.J.E., and Ying, S.Y. (2006) Transgene-like animal model using intronic microRNAs. Methods Mol Biol, 342, 321–334.
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., Kim, S., and Kim, V.N. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415–419.
Butz, S. and Larue, L. (1995) Expression of catenins during mouse embryonic development and in adult tissues. Cell Adhes Commun, 3, 337–352.
Lin, S.L., Suksaweang, S., Chuong, C.M., and Ying, S.Y. (2001) D-RNAi (Messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections. Curr Cancer Drug Targets, 1, 241–247.
Filipovska, J. and Konarska, M.M. (2000) Specific HDV RNA-templated transcription by pol II in vitro. RNA, 6, 41–54.
Modahl, L.E., Macnaughton, T.B., Zhu, N., Johnson, D.L., and Lai, M.M. (2000) RNA-dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol, 20, 6030–6039.
Vagin, V.V., Sigova, A., Li, C., Seitz, H., Gvozdev, V., and Zamore, P.D. (2006) A distinct small RNA pathway silences selfish genetic elements in the germline. Science, 313, 320–324.
Carmell, M.A., Girard, A., van de Kant, H.J., Bourc’his, D., Bestor, T.H., de Rooij, D.G., and Hamnon, G.J. (2007) MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev Cell, 12, 503–514.
Abzhanov, A., Protas, M., Grant, B.R., Grant, P.R., and Tabin, C.J. (2004) Bmp4 and morphological variation of beaks in Darwin’s finches. Science, 305, 1462–1465.
Wu, P., Jiang, T.X., Suksaweang, S., Widelitz, R.B., and Chuong, C.M. (2004) Molecular shaping of the beak. Science, 305, 1465–1466.
Sheth, U. and Parker, R. (2006) Targeting of aberrant mRNAs to cytoplasmic processing bodies. Cell, 125, 1095–1109.
Kovacs, J.A., Vogel, S., Albert, J.M., Falloon, J., Davey, R.T., Jr., Walker, R.E., Polis, M.A., Spooner, K., Metcalf, J.A., Baseler, M., Fyfe, G., and Lane, H.C. (1996) Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med, 335, 1350–1356.
Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. (2001) Stem cells, cancer, and cancer stem cells. Nature, 414, 105–111.
Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
Okita, K., Ichisaka, T., and Yamanaka, S. (2007) Generation of germline-competent induced pluripotent stem cells. Nature, 448, 313–317.
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B.E., and Jaenisch, R. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448, 318–324.
Simonsson, S. and Gurdon, J.B. (2004) DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Biol, 6, 984–990.
Murchison, E.P., Stein, P., Xuan, Z., Pan, H., Zhang, M.Q., Schultz, R.M., and Hannon, G.J. (2007) Critical roles for Dicer in the female germline. Genes Dev, 21, 682–693.
Tang, F., Kaneda, M., O’Carroll, D., Hajkova, P., Barton, S.C., Sun, Y.A., Lee, C., Tarakhovsky, A., Lao, K., and Surani, M.A. (2007) Maternal microRNAs are essential for mouse zygotic development. Genes Dev, 21, 644–648.
Suh, M.R., Lee, Y., Kim, J.Y., Kim, S.K., Moon, S.H., Lee, J.Y., Cha, K.Y., Chung, H.M., Yoon, H.S., Moon, S.Y., Kim, V.N., and Kim, K.S. (2004) Human embryonic stem cells express a unique set of microRNAs. Dev Biol, 270, 488–498.
Lin, S.L., Chang, D.C., Chang-Lin, S., Lin, C.H., Wu, D.T., Chen, D.T., and Ying, S.Y. (2008) Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA, 14, 2115–2124.
Lin, S.L., Kim, H., and Ying, S.Y. (2008) Intron-mediated RNA interference and microRNA (miRNA). Front Biosci, 13, 2216–2230.
Sherr, C.J. and Roberts, J.M. (2008) Living with or without cyclins and cyclin-dependent kinases. Genes Dev, 18, 2699–2711.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ying, SY., Chang, C.P., Lin, SL. (2010). Intron-Mediated RNA Interference, Intronic MicroRNAs, and Applications. In: Sioud, M. (eds) RNA Therapeutics. Methods in Molecular Biology, vol 629. Humana Press. https://doi.org/10.1007/978-1-60761-657-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-60761-657-3_14
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-656-6
Online ISBN: 978-1-60761-657-3
eBook Packages: Springer Protocols